📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cancer-selective targeting of the NF-?B survival pathway with GADD45ß/MKK7 inhibitors. (2014)

First Author: Tornatore L

Attributed to: Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccr.2014.07.027

PubMed Identifier: 25314077

Publication URI: http://europepmc.org/abstract/MED/25314077

Type: Journal Article/Review

Volume: 26

Parent Publication: Cancer cell

Issue: 4

ISSN: 1535-6108